Thursday’s Trading Day
|1.17|| +0.0599 / +5.40%|
As of Feb 26
|1.25|| +0.0801 / +6.85%|
Prana Biotechnology Ltd. is focused on the research and development of treatments for Alzheimer's, Huntington's disease and other major age related degenerative disorders. It is developed a proprietary library of class chemical compounds, which is combined with a drug development program to explore novel therapeutics in multiple disease indications. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Parkville, Australia.
|Geoffrey Paul Kempler||Executive Chairman & Chief Executive Officer|
|Dianne Angus||Chief Operating Officer|